Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

neurology

  • Open Access
    Updated Appropriate Use Criteria for Amyloid and Tau PET: A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
    Gil D. Rabinovici, David S. Knopman, Javier Arbizu, Tammie L.S. Benzinger, Kevin J. Donohoe, Oskar Hansson, Peter Herscovitch, Phillip H. Kuo, Jennifer H. Lingler, Satoshi Minoshima, Melissa E. Murray, Julie C. Price, Stephen P. Salloway, Christopher J. Weber, Maria C. Carrillo and Keith A. Johnson
    Journal of Nuclear Medicine January 8, 2025, jnumed.124.268756; DOI: https://doi.org/10.2967/jnumed.124.268756
  • Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
    Open Access
    Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
    Lyduine E. Collij, Gérard N. Bischof, Daniele Altomare, Ilse Bader, Mark Battle, David Vállez García, Isadora Lopes Alves, Robin Wolz, Rossella Gismondi, Andrew Stephens, Zuzana Walker, Philip Scheltens, Agneta Nordberg, Juan Domingo Gispert, Alexander Drzezga, Andrés Perissinotti, Silvia Morbelli, Christopher Buckley, Valentina Garibotto, Giovanni B. Frisoni, Gill Farrar and Frederik Barkhof; on behalf of the AMYPAD Consortium
    Journal of Nuclear Medicine January 1, 2025, 66 (1) 110-116; DOI: https://doi.org/10.2967/jnumed.124.268119
  • Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure
    You have access
    Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure
    Robel K. Gebre, Alexis Moscoso Rial, Sheelakumari Raghavan, Heather J. Wiste, Fiona Heeman, Alejandro Costoya-Sánchez, Christopher G. Schwarz, Anthony J. Spychalla, Val J. Lowe, Jonathan Graff-Radford, David S. Knopman, Ronald C. Petersen, Michael Schöll, Melissa E. Murray, Clifford R. Jack, Prashanthi Vemuri and for the Alzheimer’s Disease Neuroimaging Initiative
    Journal of Nuclear Medicine September 1, 2024, 65 (9) 1473-1480; DOI: https://doi.org/10.2967/jnumed.123.267273
  • Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620
    Open Access
    Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [18F]PI-2620
    Gérard N. Bischof, Matthias Brendel, Henryk Barthel, Hendrik Theis, Michael Barbe, Peter Bartenstein, Joseph Claasen, Adrian Danek, Günter Höglinger, Johannes Levin, Ken Marek, Bernd Neumaier, Carla Palleis, Marianne Patt, Michael Rullmann, Dorothee Saur, Matthias L. Schroeter, John Seibyl, Mengmeng Song, Andrew Stephens, Osama Sabri, Alexander Drzezga, Thilo van Eimeren and for the German Imaging Initiative for Tauopathies
    Journal of Nuclear Medicine June 1, 2024, 65 (6) 952-955; DOI: https://doi.org/10.2967/jnumed.123.265930
  • A Visual Interpretation Algorithm for Assessing Brain Tauopathy with <sup>18</sup>F-MK-6240 PET
    You have access
    A Visual Interpretation Algorithm for Assessing Brain Tauopathy with 18F-MK-6240 PET
    John P. Seibyl, Jonathan M. DuBois, Annie Racine, Jessica Collins, Qi Guo, Dustin Wooten, Eddie Stage, David Cheng, Roger N. Gunn, Lilly Porat, Alex Whittington, Phillip H. Kuo, Masanori Ichise, Robert Comley, Laurent Martarello and Cristian Salinas
    Journal of Nuclear Medicine March 1, 2023, 64 (3) 444-451; DOI: https://doi.org/10.2967/jnumed.122.264371
  • Open Access
    Molecular Imaging Findings on Acute and Long-Term Effects of COVID-19 on the Brain: A Systematic Review
    Philipp T. Meyer, Sabine Hellwig, Ganna Blazhenets and Jonas A. Hosp
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 971-980; DOI: https://doi.org/10.2967/jnumed.121.263085
  • The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review
    You have access
    The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review
    Marianne Chapleau, Leonardo Iaccarino, David Soleimani-Meigooni and Gil D. Rabinovici
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 13S-19S; DOI: https://doi.org/10.2967/jnumed.121.263195
  • You have access
    Tau PET Imaging in Neurodegenerative Disorders
    Colin Groot, Sylvia Villeneuve, Ruben Smith, Oskar Hansson and Rik Ossenkoppele
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 20S-26S; DOI: https://doi.org/10.2967/jnumed.121.263196
  • You have access
    PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
    Solveig Tiepolt, Philipp M. Meyer, Marianne Patt, Winnie Deuther-Conrad, Swen Hesse, Henryk Barthel and Osama Sabri
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 33S-44S; DOI: https://doi.org/10.2967/jnumed.121.263198
  • You have access
    Imaging Neuroinflammation in Neurodegenerative Disorders
    Joseph C. Masdeu, Belen Pascual and Masahiro Fujita
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 45S-52S; DOI: https://doi.org/10.2967/jnumed.121.263200

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2025 SNMMI

Powered by HighWire